- $1.98bn
- $2.31bn
- $2.53bn
- 95
- 75
- 81
- 97
Annual income statement for HNI, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | |
---|---|---|---|---|---|
Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,955 | 2,362 | 2,184 | 2,434 | 2,526 |
Cost of Revenue | |||||
Gross Profit | 721 | 844 | 765 | 948 | 1,038 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,894 | 2,207 | 2,099 | 2,344 | 2,320 |
Operating Profit | 61.4 | 155 | 85.4 | 90.3 | 207 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 54.4 | 146 | 78.3 | 64.8 | 179 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.9 | 124 | 59.8 | 49.2 | 140 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 41.9 | 124 | 59.8 | 49.2 | 140 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 41.9 | 124 | 59.8 | 49.2 | 140 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.79 | 2.24 | 1.63 | 2.52 | 3.06 |
Dividends per Share |